Vaccine Promising for Multiple Cancer Indications

Sellas Life Sciences announced top-line data from the Phase 2 clinical study of its WT1 cancer vaccine in patients with malignant pleural mesothelioma (MPM).

Blod Test for Cancer Relapse Promising

An experimental blood test may one day detect the return of early-stage breast cancer months before it is revealed by computed tomography or magnetic resonance imaging.

Odomzo Approved for Advanced Skin Cancer

The FDA has approved Odomzo (sonidegib) capsules for the treatment of adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

Cancer Patients Need Fertility Preservation Awareness

Many young cancer patients have limited awareness about options to preserve their fertility.

ED Drugs and Melanoma Risk

Patients taking medications for erectile dysfunction (ED) may have an increased risk of melanoma but these drugs are not a cause of melanoma.

Chili Pepper Toxin, Gallbladder Cancer Risk

Gallbladder cancer seems to be associated with aflatoxin, according to a new study.

No Link Between PTSD, Cancer

While the potential relationship between stress and cancer has been a topic of discussion and research for over 70 years, no association between post-traumatic stress disorder (PTSD) and cancer was found in the largest study to date.

Cyramza Gains Colon Cancer Indication

The FDA has expanded the indication of Cyramza (ramucirumab; Eli Lilly) for use in combination with irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed on a first line bevacizumab-, oxaliplatin- and fluoropyrimidine-containing regimen.

News

Emend Injection Gains Expanded Use in Moderately Emetogenic Chemotherapy

Emend Injection Gains Expanded Use in Moderately Emetogenic Chemotherapy

The FDA has approved Emend (fosaprepitant dimeglumine) for Injection for use in combination with other antiemetic agents to prevent delayed nausea and vomiting in adults receiving initial and repeat courses of moderately emetogenic chemotherapy (MEC).

Safety of Lipofilling Tested Post-Mastectomy

Safety of Lipofilling Tested Post-Mastectomy

Lipofilling seems safe for breast reconstruction after mastectomy for breast cancer, according to a study published in the February issue of Plastic and Reconstructive Surgery.

Complete Response Letter Issued for MCNA in Bladder CA

The Food and Drug Administration (FDA) has issued a Complete Response Letter to the Biologics License Application (BLA) for MCNA (Telesta Therapeutics) in the treatment of non-muscle invasive bladder cancer (NMIBC).

Ovarian Cancer Vaccine Granted Fast Track Status

Ovarian Cancer Vaccine Granted Fast Track Status

TapImmune announced that the Food & Drug Administration (FDA) has granted Fast Track designation for its cancer vaccine TPIV 200 in the treatment of ovarian cancer.

Colorectal Cancer Mortality Shows Global Patterns

Colorectal Cancer Mortality Shows Global Patterns

There is considerable variation in colorectal cancer (CRC) incidence and mortality rates, with the rates correlating with human development levels, according to a study published online in Gut.

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from myCME

High-Fiber Diet Now May Lead to Lower Risk of Breast Cancer LaterExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Patients Stick With Self-Screening Kit for Colon CancerExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

USPSTF Stands By Biennial Breast Cancer Screening at 50External web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters